BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 28872701)

  • 1. Natural history of pancreatic cystic lesions: A multicenter prospective observational study for evaluating the risk of pancreatic cancer.
    Ohno E; Hirooka Y; Kawashima H; Ishikawa T; Kanamori A; Ishikawa H; Sasaki Y; Nonogaki K; Hara K; Hashimoto S; Matsubara H; Hirai T; Sumi H; Sugimoto H; Goto H;
    J Gastroenterol Hepatol; 2018 Jan; 33(1):320-328. PubMed ID: 28872701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.
    Pergolini I; Sahora K; Ferrone CR; Morales-Oyarvide V; Wolpin BM; Mucci LA; Brugge WR; Mino-Kenudson M; Patino M; Sahani DV; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
    Gastroenterology; 2017 Nov; 153(5):1284-1294.e1. PubMed ID: 28739282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of intraductal papillary mucinous neoplasm and non-neoplastic cyst: long-term imaging follow-up study.
    Hisada Y; Nagata N; Imbe K; Takasaki Y; Sekine K; Tajima T; Yanase M; Fujimoto K; Akiyama J; Uemura N
    J Hepatobiliary Pancreat Sci; 2017 Jul; 24(7):401-408. PubMed ID: 28512773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors for Pancreatic Cancer and the Necessity of Long-Term Surveillance in Patients With Pancreatic Cystic Lesions.
    Yoshioka T; Shigekawa M; Ikezawa K; Tamura T; Sato K; Urabe M; Sueyoshi H; Yamai T; Suda T; Sakamori R; Tatsumi T; Takehara T
    Pancreas; 2020 Apr; 49(4):552-560. PubMed ID: 32282769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant transformation of branch duct-type intraductal papillary mucinous neoplasms of the pancreas based on contrast-enhanced endoscopic ultrasonography morphological changes: focus on malignant transformation of intraductal papillary mucinous neoplasm itself.
    Ohno E; Itoh A; Kawashima H; Ishikawa T; Matsubara H; Itoh Y; Nakamura Y; Hiramatsu T; Nakamura M; Miyahara R; Ohmiya N; Ishigami M; Katano Y; Goto H; Hirooka Y
    Pancreas; 2012 Aug; 41(6):855-62. PubMed ID: 22481289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic cancer in patients with pancreatic cystic lesions: a prospective study in 197 patients.
    Tada M; Kawabe T; Arizumi M; Togawa O; Matsubara S; Yamamoto N; Nakai Y; Sasahira N; Hirano K; Tsujino T; Tateishi K; Isayama H; Toda N; Yoshida H; Omata M
    Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1265-70. PubMed ID: 16979953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Surveillance and Timeline of Progression of Presumed Low-Risk Intraductal Papillary Mucinous Neoplasms.
    Kayal M; Luk L; Hecht EM; Do C; Schrope BA; Chabot JA; Gonda TA
    AJR Am J Roentgenol; 2017 Aug; 209(2):320-326. PubMed ID: 28590817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of Pancreatic Branch Duct Intraductal Papillary Mucinous Neoplasm Associates With Cyst Size.
    Han Y; Lee H; Kang JS; Kim JR; Kim HS; Lee JM; Lee KB; Kwon W; Kim SW; Jang JY
    Gastroenterology; 2018 Feb; 154(3):576-584. PubMed ID: 29074452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural courses of branch duct intraductal papillary mucinous neoplasm.
    Lee T; Kim HJ; Park SK; Yang HJ; Jung YS; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI; Choi KY
    Langenbecks Arch Surg; 2017 May; 402(3):429-437. PubMed ID: 28255733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Trivial" Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation?
    Marchegiani G; Andrianello S; Pollini T; Caravati A; Biancotto M; Secchettin E; Bonamini D; Malleo G; Bassi C; Salvia R
    Am J Gastroenterol; 2019 Oct; 114(10):1678-1684. PubMed ID: 31449158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.
    Canto MI; Almario JA; Schulick RD; Yeo CJ; Klein A; Blackford A; Shin EJ; Sanyal A; Yenokyan G; Lennon AM; Kamel IR; Fishman EK; Wolfgang C; Weiss M; Hruban RH; Goggins M
    Gastroenterology; 2018 Sep; 155(3):740-751.e2. PubMed ID: 29803839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms.
    Sawai Y; Yamao K; Bhatia V; Chiba T; Mizuno N; Sawaki A; Takahashi K; Tajika M; Shimizu Y; Yatabe Y; Yanagisawa A
    Endoscopy; 2010 Dec; 42(12):1077-84. PubMed ID: 21120776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fukuoka criteria accurately predict risk for adverse outcomes during follow-up of pancreatic cysts presumed to be intraductal papillary mucinous neoplasms.
    Mukewar S; de Pretis N; Aryal-Khanal A; Ahmed N; Sah R; Enders F; Larson JJ; Levy MJ; Takahashi N; Topazian M; Pearson R; Vege SS; Chari ST
    Gut; 2017 Oct; 66(10):1811-1817. PubMed ID: 27390303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mode of progression of intraductal papillary-mucinous tumor of the pancreas: analysis of patients with follow-up by EUS.
    Kobayashi G; Fujita N; Noda Y; Ito K; Horaguchi J; Takasawa O; Akaishi S; Tsuchiya T; Kobari M
    J Gastroenterol; 2005 Jul; 40(7):744-51. PubMed ID: 16082592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging of pancreatic cystic lesions with confocal laser endomicroscopy: an ex vivo pilot study.
    Kadayifci A; Atar M; Yang M; Fernandez-Del Castillo C; Mino-Kenudson M; Brugge WR
    Surg Endosc; 2017 Dec; 31(12):5119-5126. PubMed ID: 28444494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The faith of non-surveilled pancreatic cysts: a bicentric retrospective study.
    Surci N; Marchegiani G; Andrianello S; Pollini T; Mühlbacher J; Jomrich G; Richwien P; Tamandl D; Schindl M; Bassi C; Salvia R; Sahora K
    Eur J Surg Oncol; 2022 Jan; 48(1):89-94. PubMed ID: 34148825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longterm follow-up of small pancreatic cystic lesions in liver transplant recipients.
    Vidhyarkorn S; Siripongsakun S; Yu J; Sayre J; Agopian VG; Durazo F; Lu DS
    Liver Transpl; 2017 Mar; 23(3):324-329. PubMed ID: 27875639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms.
    Kamata K; Kitano M; Kudo M; Sakamoto H; Kadosaka K; Miyata T; Imai H; Maekawa K; Chikugo T; Kumano M; Hyodo T; Murakami T; Chiba Y; Takeyama Y
    Endoscopy; 2014 Jan; 46(1):22-9. PubMed ID: 24218310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
    Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
    Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.
    Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ
    Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.